• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Corcept Therapeutics

Corcept Therapeutics

  1. All
  2. Morningstar Articles
  3. Videos
  1. How We Value Berkshire Hathaway

    Alternative methods have some use, but we think discounted cash flow is the most fundamentally sound way to value the conglomerate, as we discuss in the final installment of our 5-part series.

  2. Why Berkshire's Moat Isn't Going Away Anytime Soon

    Morningstar's Gregg Warren says Berkshire's sterling balance sheet, strong business, and unique structure will sustain the firm's competitive standing--even without Buffett.

Upcoming Events
Conferences
Webinars

©2012 Morningstar Advisor. All right reserved.